GLP-1 has become a popular buzzword in the weight-loss community — but now some are touting "GLP-3s," claiming they are taking obesity medications to the next level. GLP-1 (glucagon-like peptide-1) ...
Eli Lilly and Company announced in December that its next-generation weight loss drug retatrutide helped patients shed more pounds than any other similar weight-loss drug during a late-stage trial.